Regulation of Tyrosine Hydroxylase in Dopaminergic Systems

Tyrosine hydroxylase (TH) catalyses the rate-limiting conversion of tyrosine to L-DOPA, the precursor of dopamine, and its regulation underpins the dynamics of dopaminergic neurotransmission across nigrostriatal, mesolimbic and mesocortical pathways. Control of TH activity is achieved through multiple mechanisms: feedback inhibition by catecholamine end-products, hierarchical phosphorylation of N-terminal serine residues, stabilisation by cofactors and regulatory proteins, subcellular localisation within soma and nerve terminals, and targeted degradation via the ubiquitin-proteasome system. Phosphorylation at serine 40 relieves dopamine-mediated inhibition, whereas modification at serine 19 and serine 31 primes TH for further activation and determines compartmental dependence on de novo synthesis. Transcriptional and translational control also adapt TH expression to long-term demands, as seen in stress responses and developmental programmes. Dysregulation of any of these layers contributes to motor and psychiatric disorders, most notably Parkinson’s disease and dopa-responsive dystonia, and informs strategies for precision therapies, from small molecules modulating kinase cascades to biomimetic constructs that restore continuous L-DOPA supply.

Research from Nature Portfolio

High-resolution cryo-electron microscopy has revealed the structural basis for dopamine-dependent inhibition of human TH and its reactivation by serine 40 phosphorylation, uncovering a switch in the N-terminal helix that occludes the active site in the inhibited state and is expelled upon phosphorylation. Building on these insights, nucleic acid-based artificial enzymes have been engineered to mimic TH activity in situ, crossing the blood–brain barrier and responding to pathological α-synuclein mRNA to generate continuous, localised dopa supply in models of Parkinson’s disease, thereby reducing motor deficits and synucleinopathy without the fluctuations associated with oral L-DOPA.

Regulation of Tyrosine Hydroxylase in Dopaminergic Systems publication trend

The graph below shows the total number of articles in regulation of tyrosine hydroxylase in dopaminergic systems across all publications each year (not limited to Nature Index journals).

Technical terms

Tyrosine hydroxylase (TH): The rate-limiting enzyme in catecholamine biosynthesis that converts tyrosine to L-DOPA.

Serine phosphorylation: Post-translational modification of TH at specific serine residues (e.g. Ser40, Ser31, Ser19) that alters catalytic activity and regulatory interactions.

Feedback inhibition: Autoregulatory mechanism whereby dopamine and other catecholamines bind TH to reduce its activity.

Ubiquitin-proteasome system (UPS): Cellular machinery that tags proteins, including TH, for degradation and thereby controls enzyme abundance.

Blood–brain barrier (BBB): Selective endothelial interface that regulates entry of molecules into the central nervous system.

α-Synuclein: Neuronal protein whose pathological aggregation is implicated in Parkinson’s disease and can trigger targeted enzyme-mimetic therapies.

References

1. In situ continuous Dopa supply by responsive artificial enzyme for the treatment of Parkinson’s disease. Nature Communications (2023).
2. Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits. Cell & Bioscience (2024).
3. Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms. Biochemical Society Transactions (2024).
4. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia. International Journal of Molecular Sciences (2020).
5. Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation. Nature Communications (2022).
6. Dichotomy of Tyrosine Hydroxylase and Dopamine Regulation between Somatodendritic and Terminal Field Areas of Nigrostriatal and Mesoaccumbens Pathways. PLOS ONE (2012).
7. Differential Regulation of the Human Tyrosine Hydroxylase Isoforms via Hierarchical Phosphorylation*. Journal of Biological Chemistry (2006).